Private Equity Firm Nordic Capital Leads Bids To Buy LTS Lohmann Therapie-Systeme AG

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Nordic Capital, a Stockholm-based private-equity firm, is leading bidders for LTS Lohmann Therapie-Systeme AG, which would end a nearly yearlong attempt to sell the German nicotine-patch maker, people with knowledge of the matter said. The Swedish firm may reach a deal to buy LTS Lohmann for about 1.2 billion euros ($1.7 billion) within the next month ahead of French investment firm Wendel SA (MF), said the people, who asked not to be identified because they weren’t authorized to speak publicly. The sales process has dragged out as LTS Lohmann’s three owners struggle to agree on a price at which they would be prepared to sell the business, the people said.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC